 16 citations
,
  April 2014   in “Expert Opinion on Pharmacotherapy”
           16 citations
,
  April 2014   in “Expert Opinion on Pharmacotherapy”    Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.  
      October 2023   in “International journal of rheumatic diseases”
           October 2023   in “International journal of rheumatic diseases”    New treatments targeting the JAK signaling pathway, especially JAK inhibitors, show promise for alopecia areata.  
      December 2022   in “International journal of drug regulatory affairs”
           December 2022   in “International journal of drug regulatory affairs”    The US and EU lead in cell and gene therapy regulations with more approvals and clinical trials, while India is in early stages with fewer approvals and expedited processes.  
      March 2024   in “JEADV. Journal of the European Academy of Dermatology and Venereology/Journal of the European Academy of Dermatology and Venereology”
           March 2024   in “JEADV. Journal of the European Academy of Dermatology and Venereology/Journal of the European Academy of Dermatology and Venereology”    New treatments for severe alopecia areata, especially JAK inhibitors, are recommended as first-line therapy.  
      7 citations
,
  December 2017   in “Open Access Macedonian Journal of Medical Sciences”
           7 citations
,
  December 2017   in “Open Access Macedonian Journal of Medical Sciences”    Biofibre® hair implants are safe and effective for alopecia when proper procedures are followed, with high patient satisfaction.